Table 3.
Parameter | Category | HR (95% CI) | Pr(>ChiSq) |
---|---|---|---|
Medication | ARB | 1 | |
CCB | 2.615 (0.721–9.492) | 0.144 | |
SBP (mmHg) | <129 | 1 | |
≥129 | 0.562 (0.145–2.183) | 0.405 | |
Age (years) | <75 | 1 | |
≥75 | 1.198 (0.181–7.928) | 0.851 | |
Sex | Male | 1 | |
Female | 1.432 (0.088–23.427) | 0.801 | |
Smoking | No | 1 | |
Yes | 5.751 (1.181–28.005) | 0.030 | |
Ex-smoker | 1.627 (0.314–8.425) | 0.562 | |
Statin use | No | 1 | |
Yes | 0.355 (0.046–2.731) | 0.320 | |
eGFR (mL/min/1.73 m2) | <60 | 1 | |
≥60 | 0.729 (0.131–4.044) | 0.718 | |
AAAd at baseline (cm) | <3.7 | 1 | |
≥3.7 | 1.467 (0.202–10.627) | 0.705 |
Associations are reported for the outcome, namely the incidence of surgical repair during the 24-month follow-up period vs. no evidence of surgical intervention. AAAd, abdominal aortic aneurysm diameter at baseline; HR, hazard ratio; Pr(>ChiSq), probability of obtaining a χ2 value greater than the one shown under the null hypothesis. Other abbreviations as in Tables 1,2.